121 S. Wilke Road, Suite 301, Arlington Heights, IL 60005

Home and Hospital Visits for Your Convenience

Call for a FREE Consultation

847-797-8000

FDA Approves New Crohn's Disease Medical Treatment

Posted on in FDA

Crohn's disease is an inflammatory bowel disease and can affect any portion of the gastrointestinal tract from the mouth to the anus. If this is left untreated, a patient can suffer from diarrhea, vomiting, weight loss, skin rashes, abdominal pain, lack of concentration, tiredness, eye inflammation, and even arthritis. As a result of the pain and discomfort experienced by many Crohn's patients, the search for a medical treatment has been widespread. However, a new medical treatment is on the horizon.

A press release from the FDA has announced that the agency has approved a new treatment method for both Crohn's disease and ulcerative colitis. Ulcerative colitis is another type of inflammatory bowel disease that causes the formation of ulcers in the bowels and is common to Crohn's disease.

The new medical treatment method for Crohn's and ulcerative colitis is that of Entyvio, which is an injection for adults who have moderate to severe cases of these illnesses. This new treatment has been approved to treat cases where primary methods have not helped relieve symptoms in patients.

No long range testing of the medical treatment has been conducted yet, which is always concerning, especially in a situation like this one where many individuals could be interested in trying it. As seen with numerous medical devices and treatments in past years, such as hip implants or testosterone therapy, patients find out too late about serious side effects. It is recommended that patients proceed with caution after a consultation with their personal physician.

Entyvio was approved by the FDA after clinical trials were performed on more than 900 patients whose symptoms from ulcerative colitis were not relieve by corticosteroids or immunomodulators. During the clinical trials, the patients' stool, rectal bleeding, and endoscopic findings were analyzed. The patients also received a physician assessment. Clinical trials involving 1,500 patients with Crohn's disease found that Entyvio was more effective for patients who did not see results from the aforementioned medical treatment methods.

All medical treatments come with risks, especially when new to the market. If you have already been injured by a treatment or product, you should speak with an Illinois defective device attorney today to discuss your case.

Elite Lawyer Badge Illinois State Bar Association Illinois Trial Lawyers Asscociation NACBA Manta Member BBB North western suburban bar association
Back to Top